158 related articles for article (PubMed ID: 21039734)
1. Specific and strain-independent effects of dexamethasone in the prevention and treatment of experimental autoimmune encephalomyelitis in rodents.
Donia M; Mangano K; Quattrocchi C; Fagone P; Signorelli S; Magro G; Sfacteria A; Bendtzen K; Nicoletti F
Scand J Immunol; 2010 Nov; 72(5):396-407. PubMed ID: 21039734
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
3. Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.
Mangano K; Nicoletti A; Patti F; Donia M; Malaguarnera L; Signorelli S; Magro G; Muzio V; Greco B; Zaratin P; Meroni P; Zappia M; Nicoletti F
Clin Exp Immunol; 2010 Feb; 159(2):159-68. PubMed ID: 19922500
[TBL] [Abstract][Full Text] [Related]
4. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
Ramírez F; Mason D
Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
[TBL] [Abstract][Full Text] [Related]
5. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
[TBL] [Abstract][Full Text] [Related]
6. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
Morini M; Roccatagliata L; Dell'Eva R; Pedemonte E; Furlan R; Minghelli S; Giunti D; Pfeffer U; Marchese M; Noonan D; Mancardi G; Albini A; Uccelli A
J Neuroimmunol; 2004 Mar; 148(1-2):146-53. PubMed ID: 14975595
[TBL] [Abstract][Full Text] [Related]
7. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
[TBL] [Abstract][Full Text] [Related]
8. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
9. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.
Chiba K; Kataoka H; Seki N; Shimano K; Koyama M; Fukunari A; Sugahara K; Sugita T
Int Immunopharmacol; 2011 Mar; 11(3):366-72. PubMed ID: 20955831
[TBL] [Abstract][Full Text] [Related]
10. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.
Karussis DM; Slavin S; Lehmann D; Mizrachi-Koll R; Abramsky O; Ben-Nun A
J Immunol; 1992 Mar; 148(6):1693-8. PubMed ID: 1541813
[TBL] [Abstract][Full Text] [Related]
11. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
12. The length of treatment determines whether IFN-beta prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats.
Ruuls SR; de Labie MC; Weber KS; Botman CA; Groenestein RJ; Dijkstra CD; Olsson T; van der Meide PH
J Immunol; 1996 Dec; 157(12):5721-31. PubMed ID: 8955226
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
Schorlemmer HU; Bartlett RR
Drugs Exp Clin Res; 1997; 23(5-6):175-81. PubMed ID: 9515227
[TBL] [Abstract][Full Text] [Related]
14. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.
Furlan R; Martino G; Galbiati F; Poliani PL; Smiroldo S; Bergami A; Desina G; Comi G; Flavell R; Su MS; Adorini L
J Immunol; 1999 Sep; 163(5):2403-9. PubMed ID: 10452974
[TBL] [Abstract][Full Text] [Related]
15. Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells.
Jones RE; Bourdette DN; Whitham RH; Offner H; Vandenbark AA
J Immunol; 1993 May; 150(10):4620-9. PubMed ID: 8097758
[TBL] [Abstract][Full Text] [Related]
16. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
Chen GQ; Chen YY; Wang XS; Wu SZ; Yang HM; Xu HQ; He JC; Wang XT; Chen JF; Zheng RY
Brain Res; 2010 Jan; 1309():116-25. PubMed ID: 19879252
[TBL] [Abstract][Full Text] [Related]
17. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
18. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
al-Sabbagh A; Miller A; Santos LM; Weiner HL
Eur J Immunol; 1994 Sep; 24(9):2104-9. PubMed ID: 7522160
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
20. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]